More stories
Abusive Pricing and Opportunistic Categories
Pharmaceutical products classified as "opportunistic" exploit pricing gaps and regulatory variability to drive disproportionate costs with little-to-no added clinical value. While opportunistic products represent a small fraction of overall prescription volume, their financial impact is significant. This trends analysis identifies where clinical and cost interventions can have the greatest impact.
Opioid prescriptions plunge, but questions remain over alternative pain treatments
Explore Enlyte’s latest drug trends data in Business Insurance, highlighting declining opioid prescriptions, alternative pain treatments and strategies to manage workers’ comp pharmacy costs.
For Consultants: Ten Ways We Help Your Clients Catch Risk Before Costs Escalate
Claims risk intelligence helps leaders spot emerging issues sooner. See 10 ways Enlyte connects claim data to support earlier, more informed intervention.
Specialty Solutions Spotlight: Effective Hospital Discharge Planning Starts Earlier Than You Think
When an injured employee is medically ready to leave the hospital, it doesn’t mean everything they need will be waiting when they return home or transfer to a facility. For an adjuster, the key to successful discharge planning is recognizing when coordination will be complex and choosing the right resources early.
Better Network Care Starts with the Right Provider Direction
A practical guide to compliant provider direction, network access and coordinated recovery in workers’ compensation.
Ask The Pharmacist: New OTC Opioid Alternative Available for Pain Medication
Can Tylenol and naproxen be taken together? Enlyte's pharmacist explains medication safety considerations for managing pain in workers' compensation.